Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Vicki Goodman, M.D., will become Recursion’s Chief Medical Officer ...
Louise Erdrich was getting help with her computer when her daughter discovered something on the hard drive. A short story. “‘Love of My Days’ was a forgotten file in my computer, and when I found it ...
Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $2.94, moving -6.67% from the previous trading session. This change lagged the S&P 500's daily loss of 1.67%. At the same time, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results